Ketamine is effective for treating depression, however, it can create dissociative symptoms such as feeling out of body or emotionally numb.
Researchers at Massachusetts General Hospital (MGH) recently discovered how ketamine interacts with distinct brain circuits to create its antidepressant and dissociative effects.
The study, which was published in Nature Communications, could lead to new depression treatments with fewer adverse effects.
The study included ten epileptic patients who had electrode implants in their brains to detect aberrant electrical activity that produces seizures. Before undergoing general anesthesia for electrode removal surgery, the patients were given ketamine.
They collected data on individuals’ brain activity before and after ketamine administration before removing the electrode implants.
The electrode recordings demonstrated that it produces its antidepressant and dissociative effects by engaging separate neural circuits in discrete frequency-dependent patterns of brain activity.
Ketamine caused “gamma oscillations” (25 to 55 Hz) in depression-related brain regions, notably the prefrontal cortex and hippocampus. It caused a 3 Hz oscillation in the posteromedial cortex, which is associated with dissociative symptoms.
“In this study, we show, for the first time to our knowledge in humans, a detailed description of the principal oscillatory changes in a variety of cortical and subcortical structures after administration of a subanesthetic dose of ketamine,” says lead author Fangyun Tian, Ph.D., an Instructor in the Department of Anesthesia, Critical Care and Pain Medicine at MGH and an Instructor in Anesthesia at Harvard Medical School.
more recommended stories
Microplastic Exposure and Parkinson’s Disease RiskKey Takeaways Microplastics and nanoplastics (MPs/NPs).
Sickle Cell Gene Therapy Access Expands GloballyKey Summary Caring Cross and Boston.
Reducing Alcohol Consumption Could Lower Cancer DeathsKey Takeaways (At a Glance) Long-term.
NeuroBridge AI Tool for Autism Communication TrainingKey Takeaways Tufts researchers developed NeuroBridge,.
Population Genomic Screening for Early Disease RiskKey Takeaways at a Glance Population.
Type 2 Diabetes Risk Identified by Blood MetabolitesKey Takeaways (Quick Summary) Researchers identified.
Microglia Neuroinflammation in Binge DrinkingKey Takeaways (Quick Summary for HCPs).
Precision Oncology with Personalized Cancer Drug TherapyKey Takeaways UC San Diego’s I-PREDICT.
Iron Deficiency vs Iron Overload in Parkinson’s DiseaseKey Takeaways (Quick Summary for HCPs).
Can Ketogenic Diets Help PCOS? Meta-Analysis InsightsKey Takeaways (Quick Summary) A Clinical.

Leave a Comment